ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 12 analysts with an average price target of $10.85. This is a potential upside of $9.69 (835.34%) from yesterday's end of day stock price of $1.16.

Allogene Therapeutics's activity chart (see below) currently has 129 price targets and 127 ratings on display. The stock rating distribution of ALLO is 82.35% BUY and 17.65% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.74% with an average time for these price targets to be met of 78.4 days.

Highest price target for ALLO is $14, Lowest price target is $7, average price target is $9.07.

Most recent stock forecast was given by BRIAN CHENG from JPMORGAN on 04-Aug-2025. First documented stock forecast 05-Nov-2018.

Currently out of the existing stock ratings of ALLO, 28 are a BUY (82.35%), 6 are a HOLD (17.65%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

1 months 15 days ago
(04-Aug-2025)

0/3 (0%)

$2.86 (55.64%)

Hold

$5

1 months 15 days ago
(04-Aug-2025)

1/9 (11.11%)

$3.06 (157.73%)

148

Buy

$10

$8.87 (784.96%)

4 months 5 days ago
(14-May-2025)

2/10 (20%)

$9.05 (952.63%)

94

Buy

$9

$7.87 (696.46%)

$10

4 months 5 days ago
(14-May-2025)

0/3 (0%)

$8.05 (847.37%)

Buy

$7

$5.87 (519.47%)

$9

4 months 5 days ago
(14-May-2025)

2/9 (22.22%)

$6.05 (636.84%)

3

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 78.4 days on average for the stock forecasts to be realized with a an average price target met ratio 22.74

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Mark Breidenbach has 25 price targets and 14 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Luca Issi with highest potential upside - $30.49

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Dane Leone with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?